NEW YORK, Oct. TWO (HSMN NewsFeed) — Delcath Systems, Inc. (Nasdaq: DCTH ), a laboratory technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that it appointed Krishna Kandarpa, MD, PhD, its E…
Devices, Oncology, Personnel
Delcath Systems

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President RandD and Chief Medical Officer”
Leave a Comment